Trial intelligence / Profile preview

PCV13 alternate and reduced infant immunization schedules study

2009-014315-12Phase 4Completed

Sponsor
CIB
Start
Dec 2009
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 4 trial of pneumococcal 13-valent conjugate vaccine in pneumococcal disease (3 arms), sponsored by CIB. Started Dec 2009; status: completed.

02

Drugs

pneumococcal 13-valent conjugate vaccine
03

Conditions

pneumococcal disease

Beyond the preview

Go deeper on 2009-014315-12.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-014315-12.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call